{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:00:54Z","timestamp":1792609254007,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer cells rewire metabolism to sustain high proliferation rates. Beside glycolysis and glutaminolysis, amino acids substitute as energy source, feed fatty acid biosynthesis and represent part of the secretome of transformed cells, including melanoma. We have therefore investigated acetate, pyruvate and the amino acid composition of the secretome of human melanoma cells representing the early slow (WM35, WM278, WM793b and VM21) and metastatic fast (A375, 518a2, 6F and WM8) growth phase in order to identify possible signalling components within these profiles. Proliferation assays and a principle component analysis revealed a stringent difference between the fast and slow growing melanoma cells. Moreover, upon inhibition of the mevalonate pathway, glutamic acid and alanine were identified as the central difference in the conditional media. A supplementation of the media with glutamic acid and the combination with alanine significantly accelerated the proliferation, migration and invasion of early stage melanoma cells, but not metastatic cells. Finally, the inhibition of the mevalonate pathway abolished the growth advantage of the melanoma cells in a time dependent manner. Taken together, these data corroborate a stage specific response in growth and aggressiveness to extracellular glutamic acid and alanine, indicative for microenvironmental signalling of individual amino acids.<\/jats:p>","DOI":"10.1038\/s41598-018-24709-0","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:31:43Z","timestamp":1523611903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages"],"prefix":"10.1038","volume":"8","author":[{"given":"Christine","family":"Wasinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Spadiut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hohenegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"24709_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346\u2013354 (2013).","journal-title":"Nature"},{"key":"24709_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrclinonc.2015.237","volume":"13","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder, E. I. & Hodi, F. S. Melanoma in 2015: Immune-checkpoint blockade - durable cancer control. Nat Rev Clin Oncol 13, 77\u201378 (2016).","journal-title":"Nat Rev Clin Oncol"},{"key":"24709_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/onc.2016.198","volume":"36","author":"BI Ratnikov","year":"2017","unstructured":"Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W. & Ronai, Z. A. Metabolic rewiring in melanoma. Oncogene 36, 147\u2013157 (2017).","journal-title":"Oncogene"},{"key":"24709_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/pcmr.12000","volume":"25","author":"FV Filipp","year":"2012","unstructured":"Filipp, F. V. et al. Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma. Pigment Cell Melanoma Res 25, 732\u2013739 (2012).","journal-title":"Pigment Cell Melanoma Res"},{"key":"24709_CR5","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J Biol Chem 286, 42626\u201342634 (2011).","journal-title":"J Biol Chem"},{"key":"24709_CR6","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.18632\/oncotarget.3132","volume":"6","author":"B Ratnikov","year":"2015","unstructured":"Ratnikov, B. et al. Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma. Oncotarget 6, 7379\u20137389 (2015).","journal-title":"Oncotarget"},{"key":"24709_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrc.2016.76","volume":"16","author":"PJ Mullen","year":"2016","unstructured":"Mullen, P. J., Yu, R., Longo, J., Archer, M. C. & Penn, L. Z. The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer 16, 718\u2013731 (2016).","journal-title":"Nat Rev Cancer"},{"key":"24709_CR8","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1111\/bph.12871","volume":"171","author":"C Wasinger","year":"2014","unstructured":"Wasinger, C. et al. Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. Br J Pharmacol 171, 5708\u20135727 (2014).","journal-title":"Br J Pharmacol"},{"key":"24709_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.bjp.0705928","volume":"143","author":"M Werner","year":"2004","unstructured":"Werner, M., Sacher, J. & Hohenegger, M. Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol 143, 715\u2013724 (2004).","journal-title":"Br J Pharmacol"},{"key":"24709_CR10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1476-5381.2009.00298.x","volume":"157","author":"C Minichsdorfer","year":"2009","unstructured":"Minichsdorfer, C. & Hohenegger, M. Autocrine amplification loop in statin-induced apoptosis of human melanoma cells. Br J Pharmacol 157, 1278\u20131290 (2009).","journal-title":"Br J Pharmacol"},{"key":"24709_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00210-015-1169-3","volume":"389","author":"B Atil","year":"2016","unstructured":"Atil, B., Berger-Sieczkowski, E., Bardy, J., Werner, M. & Hohenegger, M. In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin. Naunyn Schmiedebergs Arch Pharmacol 389, 17\u201332 (2016).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"24709_CR12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre, M. F., Higgins, P. D., Gruber, S. B., Hawk, E. & Lippman, S. M. Statins and cancer prevention. Nat Rev Cancer 5, 930\u2013942 (2005).","journal-title":"Nat Rev Cancer"},{"key":"24709_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","volume":"148","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor, W. A. et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148, 244\u2013258 (2012).","journal-title":"Cell"},{"key":"24709_CR14","doi-asserted-by":"publisher","first-page":"15051","DOI":"10.1073\/pnas.0910258107","volume":"107","author":"JW Clendening","year":"2010","unstructured":"Clendening, J. W. et al. Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci USA 107, 15051\u201315056 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"24709_CR15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/ijc.24885","volume":"126","author":"E Sieczkowski","year":"2010","unstructured":"Sieczkowski, E., Lehner, C., Ambros, P. F. & Hohenegger, M. Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells. Int J Cancer 126, 2025\u20132035 (2010).","journal-title":"Int J Cancer"},{"key":"24709_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/CMR.0000000000000172","volume":"25","author":"C Minichsdorfer","year":"2015","unstructured":"Minichsdorfer, C., Wasinger, C., Sieczkowski, E., Atil, B. & Hohenegger, M. Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells. Melanoma Res 25, 284\u2013294 (2015).","journal-title":"Melanoma Res"},{"key":"24709_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.devcel.2016.02.012","volume":"36","author":"AM Hosios","year":"2016","unstructured":"Hosios, A. M. et al. Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells. Dev Cell 36, 540\u2013549 (2016).","journal-title":"Dev Cell"},{"key":"24709_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583\u2013594 (2010).","journal-title":"Cell"},{"key":"24709_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6712","volume":"5","author":"J Muller","year":"2014","unstructured":"Muller, J. et al. Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat Commun 5, 5712 (2014).","journal-title":"Nat Commun"},{"key":"24709_CR20","doi-asserted-by":"publisher","first-page":"55128","DOI":"10.18632\/oncotarget.10422","volume":"7","author":"TN Alver","year":"2016","unstructured":"Alver, T. N. et al. MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma. Oncotarget 7, 55128\u201355140 (2016).","journal-title":"Oncotarget"},{"key":"24709_CR21","first-page":"528","volume":"143","author":"I Juhasz","year":"1993","unstructured":"Juhasz, I. et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 143, 528\u2013537 (1993).","journal-title":"Am J Pathol"},{"key":"24709_CR22","doi-asserted-by":"publisher","first-page":"e45190","DOI":"10.1371\/journal.pone.0045190","volume":"7","author":"J De Ingeniis","year":"2012","unstructured":"De Ingeniis, J. et al. Functional specialization in proline biosynthesis of melanoma. PLoS One 7, e45190 (2012).","journal-title":"PLoS One"},{"key":"24709_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MCO.0000000000000121","volume":"18","author":"JM Phang","year":"2015","unstructured":"Phang, J. M., Liu, W., Hancock, C. N. & Fischer, J. W. Proline metabolism and cancer: emerging links to glutamine and collagen. Curr Opin Clin Nutr Metab Care 18, 71\u201377 (2015).","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"24709_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"key":"24709_CR25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43, 869\u2013874 (2011).","journal-title":"Nat Genet"},{"key":"24709_CR26","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1111\/j.1742-4658.2011.08174.x","volume":"278","author":"A Herling","year":"2011","unstructured":"Herling, A., Konig, M., Bulik, S. & Holzhutter, H. G. Enzymatic features of the glucose metabolism in tumor cells. FEBS J 278, 2436\u20132459 (2011).","journal-title":"FEBS J"},{"key":"24709_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-3002-2-23","volume":"2","author":"JJ Kamphorst","year":"2014","unstructured":"Kamphorst, J. J., Chung, M. K., Fan, J. & Rabinowitz, J. D. Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. Cancer Metab 2, 23 (2014).","journal-title":"Cancer Metab"},{"key":"24709_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","volume":"28","author":"C Cheng","year":"2015","unstructured":"Cheng, C. et al. Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. Cancer Cell 28, 569\u2013581 (2015).","journal-title":"Cancer Cell"},{"key":"24709_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","volume":"23","author":"Z Luan","year":"2003","unstructured":"Luan, Z., Chase, A. J. & Newby, A. C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 23, 769\u2013775 (2003).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"24709_CR30","first-page":"885","volume":"11","author":"IF Kretzer","year":"2016","unstructured":"Kretzer, I. F., Maria, D. A., Guido, M. C., Contente, T. C. & Maranhao, R. C. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice. Int J Nanomedicine 11, 885\u2013904 (2016).","journal-title":"Int J Nanomedicine"},{"key":"24709_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00210-011-0623-0","volume":"383","author":"TC Izidoro-Toledo","year":"2011","unstructured":"Izidoro-Toledo, T. C., Guimaraes, D. A., Belo, V. A., Gerlach, R. F. & Tanus-Santos, J. E. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 383, 547\u2013554 (2011).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"24709_CR32","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","volume":"367","author":"SF Nielsen","year":"2012","unstructured":"Nielsen, S. F., Nordestgaard, B. G. & Bojesen, S. E. Statin use and reduced cancer-related mortality. N Engl J Med 367, 1792\u20131802 (2012).","journal-title":"N Engl J Med"},{"key":"24709_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ijc.30526","volume":"140","author":"Z Mei","year":"2017","unstructured":"Mei, Z. et al. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. Int J Cancer 140, 1068\u20131081 (2017).","journal-title":"Int J Cancer"},{"key":"24709_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise, D. R. & Thompson, C. B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35, 427\u2013433 (2010).","journal-title":"Trends Biochem Sci"},{"key":"24709_CR35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0021-9258(18)65826-0","volume":"218","author":"H Eagle","year":"1956","unstructured":"Eagle, H., Oyama, V. I., Levy, M., Horton, C. L. & Fleischman, R. The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J Biol Chem 218, 607\u2013616 (1956).","journal-title":"J Biol Chem"},{"key":"24709_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature19347","volume":"537","author":"C Luo","year":"2016","unstructured":"Luo, C. et al. A PGC1alpha-mediated transcriptional axis suppresses melanoma metastasis. Nature 537, 422\u2013426 (2016).","journal-title":"Nature"},{"key":"24709_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E","volume":"71","author":"W Berger","year":"1997","unstructured":"Berger, W. et al. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer 71, 108\u2013115 (1997).","journal-title":"Int J Cancer"},{"key":"24709_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbiotec.2017.11.010","volume":"265","author":"A Hofer","year":"2018","unstructured":"Hofer, A. et al. Prediction of filamentous process performance attributes by CSL quality assessment using mid-infrared spectroscopy and chemometrics. J Biotechnol 265, 93\u2013100 (2018).","journal-title":"J Biotechnol"},{"key":"24709_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0169-7439(01)00155-1","volume":"58","author":"S Wold","year":"2001","unstructured":"Wold, S., Sjostrom, M. & Eriksson, L. PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab 58, 109\u2013130 (2001).","journal-title":"Chemometr Intell Lab"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24709-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24709-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24709-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:13:41Z","timestamp":1720224821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24709-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24709"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24709-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6245"}}